Content related to Improving Long-Term Effects of Radiation in Children: A Research-Based Labor of Love

Medulloblastoma, the most common malignant brain tumor occurring in children, is a fast-growing cancer that affects nearly 2 million people – including adults – annually. Traditionally

Researchers at Children’s Hospital Los Angeles led a multi-institutional study that pins down, for the first time, the actual risk of hearing loss from cisplatin, a common chemotherapy agent

While other toddlers her age were fighting naptime, two-year-old Michelle was battling an aggressive, life-threatening cancer. Doctors at Children’s Hospital Los Angeles saved her life in an epic

Researchers have been delving deeper to better understand long-term cancer survival and quality of life for adolescent and young adult patients.

New clinic provides comprehensive screening and treatment for children with endocrine issues caused by cancer treatment.

A CHLA oncologist led a pivotal clinical trial leading to the approval of the first drug to prevent cisplatin hearing loss in children.

Peter Chiarelli, MD, DPhil, is combining chemistry, physics and nanoscience to find new therapies for diffuse intrinsic pontine gliomas.